The invisible burden - The challenge of untreated hepatocellular carcinoma.
사설/논평
1/5 보강
This editorial explores the situation of patients with hepatocellular carcinoma (HCC) who, due to advanced frailty, multiple health conditions, personal choice, or terminal disease stage, are not cand
APA
Lledó Navarro JL (2025). The invisible burden - The challenge of untreated hepatocellular carcinoma.. Revista espanola de enfermedades digestivas, 117(9), 487-489. https://doi.org/10.17235/reed.2025.11454/2025
MLA
Lledó Navarro JL. "The invisible burden - The challenge of untreated hepatocellular carcinoma.." Revista espanola de enfermedades digestivas, vol. 117, no. 9, 2025, pp. 487-489.
PMID
40737272 ↗
Abstract 한글 요약
This editorial explores the situation of patients with hepatocellular carcinoma (HCC) who, due to advanced frailty, multiple health conditions, personal choice, or terminal disease stage, are not candidates for active cancer treatment. Despite progress in early diagnosis, a notable percentage of these individuals receive only comfort-oriented care. The article reviews how their prognosis is largely determined by the severity of liver failure and overall health status, while tumor features such as extent and vascular invasion, along with high tumor markers, further diminish survival prospects. It also discusses the influence of social context and patient decisions on outcomes. The editorial advocates for a care model focused on alleviating symptoms, respecting patient preferences, and improving quality of life through palliative interventions. It calls for more inclusive research and healthcare strategies that address the specific needs of these patients, emphasizing the importance of compassion, respect, and tailored support during the final stages of illness.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.